Title : Satisfaction and efficacy of switching from daily dipeptidyl peptidase-4 inhibitors to weekly trelagliptin in patients with type 2 diabetes-Randomized controlled study.

Pub. Date : 2018 Feb 26

PMID : 29093280






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Switching from daily DPP-4 inhibitors to a weekly DPP-4 inhibitor, trelagliptin, could partially improve treatment satisfaction levels in patients with type 2 diabetes without affecting glycemic control. trelagliptin dipeptidyl peptidase 4 Homo sapiens